Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2)-Reference-Cited by-同舟云学术

Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2)

Published:2023-11-28 Issue:23 Volume:24 Page:16865
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Lymperopoulos Anastasios¹^ORCID

Affiliation:

1. Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL 33328-2018, USA

Abstract

The goal of the second volume of this Special Issue was to build upon the success of the first one and to continue to highlight the ever-expanding list of pharmacological properties of the sodium/glucose co-transporter (SGLT) type 2 (SGLT2) inhibitor (SGLT2i) drug class (also known as gliflozins) [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/23/16865/pdf

Reference20 articles.

1. Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis;Packer;Circulation,2022

2. Voors, A.A. (J. Card Fail., 2023). Novel Recommendations for the Treatment of Patients with Heart Failure: 2023 Focused Update of the 2021 ESC Heart Failure Guidelines, J. Card Fail., Online ahead of print.

3. Empagliflozin, calcium, and SGLT1/2 receptor affinity: Another piece of the puzzle;Anker;ESC Heart Fail.,2018

4. Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: Characterisation and comparison with other SGLT-2 inhibitors;Grempler;Diabetes Obes. Metab.,2012

5. Kurtz, R., Libby, A., Jones, B.A., Myakala, K., Wang, X., Lee, Y., Knoer, G., Lo Cascio, J.N., McCormack, M., and Nguyen, G. (2022). Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice. Int. J. Mol. Sci., 23.